COMPANY
Tailstorm Health Inc. dba Medivant Health
Tailstorm Health Inc. dba Medivant Health: warning letter recipient for Semaglutide, Tirzepatide, as stated by public registers.
WARNING LETTER RECIPIENT
Received an FDA warning letter naming the peptide.
| Semaglutide | Compounding Pharmacy/Adulterated Drug Products, 2025-04-08 Regulator FDA warning letters |
|---|---|
| Tirzepatide | Compounding Pharmacy/Adulterated Drug Products, 2025-04-08 Regulator FDA warning letters |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.